Delhi based healthtech startup BeatO has raised Rs 42 crore in its pre-Series B round of funding led by W Health Ventures. PharmEasy, Merisis VP, and existing investors Orios VP, Leo Capital, and others have also participated.
According to the company, the proceeds will be used towards the expansion of its subscriber base and strengthen its product capabilities. With the latest funding, BeatO has raised Rs 75 crore over the last year across its Series A and pre-Series B rounds.
Founded by Gautam Chopra, Yash Sehgal, and Abhishek Kumar, BeatO provides a full-stack diabetes management programme that helps the user manage exercising, diet, medicine intake, and diagnosis, and connects the users with doctors and diabetes educators for instant real-time guidance.
The startup claims to have 300,000 paid members on its platform, adding 25,000 members every month.
PharmEasy, which recently acquired listed diagnostics firm Thyrocare, will also partner with BeatO to build technology and new products to improve the health outcomes of patients with chronic conditions.
